Business
WORK Medical Technology Group LTD Announces Receipt of Delisting Determination Letter from Nasdaq
Hangzhou, China, Oct. 14, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that the Company received a determination letter, dated October 9, 2025 (the “Letter”), from the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company of Na
About this update from Work Medical Technology Group Ltd
[{"type":"image","alt":"WORK Medical Technology Group LTD","displaySize":"","headline":null,"caption":"WORK Medical Technology Group LTD","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":115,"url":"https://media.zenfs.com/en/globenewswire.com/5c6f5c9b0e45051eb176e780086eddda"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/uUDJ_rnqH5.z3pxoEsuqXQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE2MTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/5c6f5c9b0e45051eb176e780086eddda","width":300,"height":115}},"lazy":false},{"type":"text","content":"Hangzhou, China, Oct. 14, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that the Company received a determination letter, dated October 9, 2025 (the “Letter”), from the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company of Nasdaq’s determination to delist the Company’s Class A ordinary shares from The Nasdaq Capital Market, because the Company’s Class A ordinary shares had a closing bid price of $0.10 or less for ten consecutive trading days ending October 8, 2025, which triggered a notice of delisting pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(iii).","length":834,"tagName":"p"},{"type":"text","content":"Pursuant to the Letter, unless the Company requests an appeal, trading of the Company’s Class A ordinary shares will be suspended at the opening of business on October 20, 2025, and a Form 25-NSE will be filed with the U.S. Securities and Exchange Commission to remove the Company’s securities from listing and registration on Nasdaq.","length":339,"tagName":"p"},{"type":"text","content":"The Company has the right to request a hearing before a Nasdaq Hearings Panel (the “Panel”) to appeal this determination, with such request due by October 16, 2025. A request for a hearing will stay the suspension of the Company’s securities pending the Panel’s decision. The Company plans to appeal the determination to the Panel on or before October 16, 2025.","length":366,"tagName":"p"},{"type":"text","content":"The Company will consider all available options to regain compliance with the Nasdaq Listing Rules for co...